Brain

Datasea Announces Major Acoustic Technology Advancements in Brain-Computer Interface Applications

Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain–Computer Interface MarketBEIJING, Jan. 12, 2026…

4 weeks ago

MediKarma Launches Healthcare’s First “Agentic AI” Licensing Model: Opens Access to Validated Disease Management Agents

MediKarma is the "Intel Inside" of the healthcare economy. Payers and platforms can now license specific AI Agents – longevity,…

4 weeks ago

Kandu, Inc. Announces Appointment of Marshal Linder to Board of Directors and Strategic Growth Investment from K2 HealthVentures and Piper Sandler Merchant Bank

LOS ANGELES, Jan. 12, 2026 /PRNewswire/ -- Kandu, Inc., a healthcare technology company pioneering integrated stroke recovery solutions for post-stroke…

4 weeks ago

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Experienced medical executive advances to permanent role following successful leadership as Interim CMOSEATTLE and VANCOUVER, British Columbia, Jan. 12, 2026…

4 weeks ago

Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs

– First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries – Investigator-Initiated (IIT) funded pancreatic and…

4 weeks ago

Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference

Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026Five additional…

4 weeks ago

ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones

Announced rinzimetostat (ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds…

4 weeks ago